Medigen Biotechnology Corp. (TPEX:3176)
Taiwan · Delayed Price · Currency is TWD 29.90
+0.15 (0.50%)
Sep 5, 2025, 1:30 PM CST
Medigen Biotechnology Market Cap
Medigen Biotechnology has a market cap or net worth of 4.17 billion as of September 5, 2025. Its market cap has decreased by -20.01% in one year.
Market Cap
4.17B
Enterprise Value
5.92B
Revenue
1.63B
Ranking
n/a
PE Ratio
n/a
Stock Price
29.90
Market Cap Chart
Since November 3, 2004, Medigen Biotechnology's market cap has increased from 684.56M to 4.17B, an increase of 508.46%. That is a compound annual growth rate of 9.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 4.17B | -7.72% |
| Dec 31, 2024 | 4.51B | -27.70% |
| Dec 29, 2023 | 6.24B | 33.24% |
| Dec 30, 2022 | 4.69B | -41.43% |
| Dec 30, 2021 | 8.00B | -2.78% |
| Dec 31, 2020 | 8.23B | -4.46% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 394.73B |
| PharmaEssentia | 171.63B |
| Bora Pharmaceuticals Co., LTD. | 91.84B |
| Lotus Pharmaceutical | 51.15B |
| Lumosa Therapeutics | 40.18B |
| Oneness Biotech | 36.35B |
| Polaris Group | 29.31B |
| Center Laboratories | 28.67B |